Ono Pharmaceutical Co., Ltd.
4528.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥22,499 | ¥17,589 | -¥6,545 | ¥14,951 |
| Dep. & Amort. | ¥9,313 | ¥9,238 | ¥8,728 | ¥9,170 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | ¥12,461 | -¥24,280 | ¥39,077 | ¥3,937 |
| Other Non-Cash | ¥6,918 | ¥826 | -¥2,264 | -¥19,318 |
| Operating Cash Flow | ¥51,191 | ¥3,373 | ¥38,996 | ¥8,740 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥1,988 | -¥48,042 | -¥1,421 | -¥1,204 |
| Net Acquisitions | ¥7 | ¥0 | ¥0 | ¥0 |
| Inv. Purchases | -¥1,263 | -¥170 | ¥0 | ¥0 |
| Inv. Sales/Matur. | ¥4,804 | ¥5,769 | ¥0 | ¥0 |
| Other Inv. Act. | -¥334 | -¥600 | ¥16,747 | ¥10,023 |
| Investing Cash Flow | ¥1,226 | -¥43,043 | ¥15,326 | ¥8,819 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥7,500 | -¥7,500 | -¥8,306 | -¥7,500 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | -¥1 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | -¥1,369 | -¥17,396 | -¥992 | -¥17,770 |
| Other Fin. Act. | -¥834 | -¥861 | ¥0 | -¥820 |
| Financing Cash Flow | -¥9,704 | -¥25,757 | -¥9,298 | -¥26,090 |
| Forex Effect | ¥356 | -¥149 | -¥1,442 | ¥2,424 |
| Net Chg. in Cash | ¥43,069 | -¥65,576 | ¥43,585 | -¥6,108 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥138,991 | ¥204,567 | ¥160,982 | ¥167,090 |
| End Cash | ¥182,060 | ¥138,991 | ¥204,567 | ¥160,982 |
| Free Cash Flow | ¥49,531 | ¥1,123 | ¥37,575 | ¥7,536 |